Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Atara Biotherapeutics
(AT20.F) Q2 2026
Earnings
AT20.F
May 12
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.77
-0.14
1.5
3.13
Details
Expected EPS
-0.28075882067
Actual EPS
-0.2470771
Surprise EPS
0.03
Surprise Percent
+12%
Description
Atara Biotherapeutics (AT20.F) has reported earnings of -0.2470771 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login